TY - JOUR
T1 - Preparation of the glucosylamines of procainamide and evaluation of the pharmacokinetics of the beta-glucosylamine of procainamide in the conscious rabbit
AU - Parkin, J.E.
AU - Ilett, Kenneth
PY - 1997
Y1 - 1997
N2 - An aqueous solution of the glucosylamines formed when procainamide reacts with glucose has been prepared and the kinetics of the elimination of the beta-anomer has been investigated in the conscious rabbit. Analytical methods were developed for the beta-ducosylamine and for both procainamide and N-acetylprocainamide. The beta-glucosylamine was not converted to procainamide in vivo and showed monoexponential elimination kinetics with a mean (+/- 1 S.D.) t(1/2) of 0.92 +/- 0.11 h and a V-z of 0.16 +/- 0.03 1/kg as opposed to 0.93 +/- 0.10 h and 6.09 +/- 1.17 1/kg, respectively for procainamide. Simulations using this data indicated that administration of an infusion of procainamide hydrochloride in 5% glucose to human subjects could result in steady-state plasma concentrations of the beta-glucosylamine which are fifteen times greater than for procainamide. The biological activity of the glucosylamines of procainamide remains to be studied. (C) 1997 Elsevier Science B.V.
AB - An aqueous solution of the glucosylamines formed when procainamide reacts with glucose has been prepared and the kinetics of the elimination of the beta-anomer has been investigated in the conscious rabbit. Analytical methods were developed for the beta-ducosylamine and for both procainamide and N-acetylprocainamide. The beta-glucosylamine was not converted to procainamide in vivo and showed monoexponential elimination kinetics with a mean (+/- 1 S.D.) t(1/2) of 0.92 +/- 0.11 h and a V-z of 0.16 +/- 0.03 1/kg as opposed to 0.93 +/- 0.10 h and 6.09 +/- 1.17 1/kg, respectively for procainamide. Simulations using this data indicated that administration of an infusion of procainamide hydrochloride in 5% glucose to human subjects could result in steady-state plasma concentrations of the beta-glucosylamine which are fifteen times greater than for procainamide. The biological activity of the glucosylamines of procainamide remains to be studied. (C) 1997 Elsevier Science B.V.
UR - https://www.scopus.com/pages/publications/0031398807
U2 - 10.1016/S0939-6411(96)00034-3
DO - 10.1016/S0939-6411(96)00034-3
M3 - Article
VL - 43
SP - 139
EP - 143
JO - European Journal of Pharmaceutics and Biopharmaceutics
JF - European Journal of Pharmaceutics and Biopharmaceutics
ER -